TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $437,398 | -0.5% | 28,274 | +1.0% | 0.01% | 0.0% |
Q2 2023 | $439,612 | +25.8% | 27,983 | +32.0% | 0.01% | +18.2% |
Q1 2023 | $349,376 | +115971.8% | 21,200 | +9.7% | 0.01% | +22.2% |
Q4 2022 | $301 | -99.9% | 19,326 | -51.3% | 0.01% | 0.0% |
Q3 2022 | $257,257 | +48.7% | 39,670 | +221.1% | 0.01% | +50.0% |
Q2 2022 | $173,000 | +2.4% | 12,355 | +4.5% | 0.01% | 0.0% |
Q1 2022 | $169,000 | +4.3% | 11,828 | -0.4% | 0.01% | 0.0% |
Q4 2021 | $162,000 | -19.8% | 11,880 | -3.8% | 0.01% | -25.0% |
Q3 2021 | $202,000 | -2.9% | 12,347 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $208,000 | – | 12,347 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |